"Concise industry news from the US pharmaceutical industry..."
New Account

The Magazine

Issue 12

Issue 12 E-magazine
  • Previous Issues

Sponsors

Platinum Sponsors
Gold Sponsors
Silver Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors

Blog

Where our team of guest writers discuss what they think about the current NGP US Issues.

Peter Duncan
Director of Business Development

Can digital pathology save drug development?

Peter Duncan of Definiens discusses the potential of digital pathology.
07 Jul 2010
Manufacturing
1 of 2 Previous | Next
Manufacturing

Leading Lilly Forward


John Lechleiter, newly appointed CEO of Eli Lilly, addresses Lilly’s stance in the industry and reveals the directions in which he’ll be taking the company after stepping into the leadership role on April 1.

No Comments

The Importance of Operations


Ken Murtha, Regional Vice President Supply for the Americas for AstraZeneca, talks about operations, supply chain management and counterfeit medicines.

No Comments

The New Risk Management Paradigm


Jill Robinson and Mary Ellen Turner of the Global Safety Surveillance, Epidemiology, and Labeling Group at Wyeth Research discuss their approach to risk management.

No Comments

Big in Germany


Acquisitions, mergers, collaborations – everyone’s doing it. Take Bayer, for example, who bought Schering in June 2006 in a deal worth over $27 billion. The intention: to become a global healthcare heavyweight. NGP spoke with Dr. Andreas Busch, Head of Global Drug Discovery, Bayer Schering Pharma, about R&D after the merger.

No Comments

Performance Validation, LLC Next Generation Pharmaceuticals


Customer centric focus: Customer focus has been defined as placing the wants and needs of the customer as the central focus of all business practices within the company. By Performance Validation

No Comments
1 of 2 Previous | Next